Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Trader J's Inner Circle -- Ignore unavailable to you. Want to Upgrade?

To: Spark who wrote (9358)	2/18/1999 8:59:00 PM
From: Mike McFarland	Respond to of 56535

Mike, What do you think of ARIA? Well I think the stock is not making me a lot of money, heheh. I guess I keep waiting for Aventis (Hoechst and Rhone- Poulenc) to come out with some announcment of a collaboration with the Hoechst-Ariad Genomics Center...the kind of annoucment that will set off articles in the business section that use cliches like synergy and such. Recall that Ariad is working with Pangea, which seems to be one of the real bioinformatics players (it is a private company, so no symbol for Pangea). Speaking of bioinformatics...I did get some Curagen the other day, it came down to a flip of the coin between Gene Logic and CRGN. Ariad is only my fifth largest holding...so I am not in love with the position.